Abstract
A.M. Sheedy et al. present a replenishable implant that enables repeated delivery of therapies directly to the peritoneum for ovarian cancer treatment. This minimally invasive platform improves therapeutic efficacy and allows longitudinal fluid sampling to monitor disease response.
| Original language | English (US) |
|---|---|
| Article number | 101050 |
| Journal | Device |
| Volume | 4 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 20 2026 |
Bibliographical note
Publisher Copyright:© 2026 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- DTI-3: Develop
- local peritoneal delivery
- natural killer cell immunotherapy
- ovarian cancer
- replenishable peritoneal implant
- sampling tumor microenvironment
Fingerprint
Dive into the research topics of 'A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS